Rigorous evaluation through clinical testing is vital for advancing safe and effective therapies. Clinical trials in regenerative medicine assess how engineered tissues, cell therapies, and gene editing approaches perform in human subjects across a spectrum of conditions. These trials must balance innovation with patient safety, following tightly regulated frameworks to validate therapeutic efficacy and monitor adverse outcomes. From early-phase feasibility studies to large-scale randomized trials, each stage is shaped by complex logistics, including manufacturing standards, delivery methods, and biomarker development. Clinical trials in regenerative medicine also face unique challenges like variability in cell behavior, individualized responses, and long-term monitoring. Despite these hurdles, progress continues steadily, establishing confidence in regenerative approaches through evidence-based evaluation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Planar microorganoPit-based co-culture platform (MICA) for studying tumor-immune interactions in patient-derived tumoroids
Xiaochun Cao Ehlker, HTCR-Services GmbH, Martinsried/Planegg, Germany
Title : Comparing the effect of using calcified autogenous nano dentin particles versus micro dentin particles in the healing of mandibular bony defects in New Zealand rabbits
Sarah Yasser, Oral Biology Department, Faculty of Dentistry, Tanta University, Egypt
Title : Channel fidelity limits in in-wound hydrogel printing for cartilage regeneration
Evgenia Papadimitriou, AVT.CVT, RWTH University, Germany
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom